glp-1 obesity drug study august 2025 A network meta-analysis backed weight-loss benefits with several receptor agonists, with less certainty for newer-generation agents. Read more at the link in bio GLP-1 Agonists Weight Loss Drugs

Patients were required to have at least one baseline measurement of weight or HbA1c within a year before drug initiation and one follow-up measurement between 9 and 15 months after initiation

Understanding Semaglutide and Menopause-Related Weight Gain Erica*, 48, from South Jersey, says no amount of calorie-cutting, hot yoga, or Pilates could budge the 12 pounds she acquired during perimenopause, much of it around the waistline

doi: 10.1113/jphysiol.1970.sp009155

Come for the culture shift, stay for the vision of wellness that isnt just digitalbut deeply human

4951,56 Orforglipron achieved even greater reductions, lowering HbA1c by up to 2.1% and weight by up to 10.1 kg